Caliper Life Sciences said it saw a 10% increase in revenue for its current operations on a reported basis. "We continue to see strong demand for our LabChip and Imaging platforms driven by growing market investment in molecular imaging, genomics and targeted therapeutic research applications," President and CEO Kevin Hrusovsky said.

Full Story:
PR Newswire

Related Summaries